Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.27M Buy
5,794
+972
+20% +$194K 0.6% 12
2020
Q1
$835K Buy
+4,822
New +$797K 0.38% 91
2019
Q2
Sell
-12,730
Closed -$2.04M 327
2019
Q1
$2.04M Buy
+12,730
New +$1.97M 0.35% 154
2017
Q2
Sell
-5,819
Closed -$785K 172
2017
Q1
$785K Buy
+5,819
New +$754K 0.17% 123

Other funds holding CLX

361 Capital's CLX Position: Q2 2020 in Review

361 Capital increased its Clorox (CLX) stake by 20% in Q2 2020, buying an estimated $194K and bringing the position to 5,794 shares worth $1.27M. The position accounts for 0.6% of the portfolio, ranked #12.

361 Capital first reported a position in CLX in Q1 2017 and has held it in 4 quarters since. The position peaked at $2.04M in Q1 2019. 1,197 funds tracked by Wall St. Rank hold CLX as of Q2 2020.

  • 361 Capital held 5,794 shares of Clorox worth $1.27M as of Q2 2020.
  • 361 Capital bought 972 Clorox shares in Q2 2020, an estimated $194K.
  • Clorox made up 0.6% of 361 Capital's portfolio in Q2 2020, its #12 holding.
  • 361 Capital first reported a position in Clorox in Q1 2017 and has held it in 4 quarters since.
  • 361 Capital's Clorox position peaked at $2.04M in Q1 2019.
  • 1,197 funds tracked by Wall St. Rank held Clorox as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.